Skip to main content
letter
. 2020 Jul 6;20:100253. doi: 10.1016/j.ensci.2020.100253

Table 1.

Characteristics of patients with and without early neurological deterioration.


Early neurological deterioration

With
Without
p
(n = 11) (n = 59)
Background characteristics
Male, n (%) 6 (54.6) 41 (69.5) 0.4853
Age, years, mean (SD) 75.1 (14.6) 71.9 (12.5) 0.4576



History of
Ischemic stroke, n (%) 2 (18.2) 7 (11.9) 0.6249
Ischemic heart disease, n (%) 0 (0.0) 8 (13.6) 0.3400
Hypertension, n (%) 9 (81.8) 39 (66.1) 0.4825
Diabetes mellitus, n (%) 5 (45.5) 20 (33.9) 0.5056
Dyslipidemia, n (%) 5 (45.5) 23 (39.0) 0.7447
Current smoking, n (%) 2 (18.2) 18 (30.5) 0.4935



Premorbid
Antiplatelet agents, n (%) 2 (18.2) 13 (22.0) 1.0000
Antihypertensive agents, n (%) 7 (63.6) 33 (55.9) 0.7472
Hypoglycemic agents, n (%) 5 (45.5) 14 (23.7) 0.1548
Statin, n (%) 4 (36.4) 14 (23.7) 0.4561
NIHSS, median (IQR) 3 (2–6) 3 (1–5) 0.6950
SBP on admission, mmHg, mean (SD) 171.6 (33.9) 164.1 (28.7) 0.4421
DBP on admission, mmHg, mean (SD) 88.5 (20.1) 87.8 (15.5) 0.8837



Blood test findings, median (IQR)
Hematocrit, % 41.4 (36.1–42.8) 41.2 (38.3–43.9) 0.3492
Aspartate aminotransferase, U/L 19 (14–23) 18 (16–23) 0.9161
Alanine aminotransferase, U/L 12 (8–36) 15 (10−21) 0.6567
γ-glutamyl transpeptidase, U/L 29 (17–45) 24.5 (17–33) 0.7605
Lactate dehydrogenase, U/L 194 (180–256) 192 (168–210) 0.2867
Alkaline phosphatase, U/L 296 (233–338) 216 (187–262) 0.0081
eGFR 70.2 (58.8–78.7) 62.6 (53.3–70.6) 0.1175
LDL-cholesterol, mg/dL 103 (88–134) 125 (93–145) 0.2485
HDL-cholesterol, mg/dL 42 (38–54) 42 (37–54) 0.8844
Triglyceride, mg/dL 122 (56–165) 117 (80.5–211) 0.4790
Glucose, mg/dL 136 (117–158) 124 (104–163) 0.3492
Hemoglobin A1c, % 6.25 (5.775–7.425) 6.05 (5.7–6.625) 0.4364
CRP, mg/dL 0.37 (0.08–2.24) 0.18 (0.06–0.34) 0.1011
D-dimer, ng/mL 1 (0.7–3.6) 0.8 (0.6–1.2) 0.2131

SD indicates standard deviation; IQR, interquartile range; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CRP, C-reactive protein.